Advertisement

Topics

Servier, Transgene to apply viral vectorization technology to engineering of allogenic CAR-T

05:43 EDT 30 Jun 2017 | Pharmaceutical Business Review

Servier and Transgene have signed a research agreement on the application of viral vectorization technology for the production of allogenic CAR-T cell therapies.

Original Article: Servier, Transgene to apply viral vectorization technology to engineering of allogenic CAR-T

NEXT ARTICLE

More From BioPortfolio on "Servier, Transgene to apply viral vectorization technology to engineering of allogenic CAR-T"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...